RxSight (RXST) Operating Income (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.14% |
| Dec 31, 2025 | 6.83% |
| Sep 30, 2025 | 13.03% |
| Jun 30, 2025 | -31.19% |
| Mar 31, 2025 | -23.71% |
| Dec 31, 2024 | 6.48% |
| Sep 30, 2024 | -10.72% |
| Jun 30, 2024 | 21.90% |
| Mar 31, 2024 | 1.68% |
| Dec 31, 2023 | 13.27% |
| Sep 30, 2023 | 8.17% |
| Jun 30, 2023 | -4.03% |
| Mar 31, 2023 | -138.17% |
| Dec 31, 2022 | 315.01% |
| Sep 30, 2022 | -1.05% |
| Jun 30, 2022 | 4.74% |
| Mar 31, 2022 | -13.06% |
| Dec 31, 2021 | -11.83% |
| Sep 30, 2021 | 5.51% |
| Jun 30, 2021 | -24.63% |
| Mar 31, 2021 | -34.12% |
| Dec 31, 2020 | 6.78% |
| Sep 30, 2020 | -1.12% |